The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer

[1]  K. Westerterp,et al.  Effects of medroxyprogesterone acetate on food intake, body composition, and resting energy expenditure in patients with advanced, nonhormone‐sensitive cancer , 1998, Cancer.

[2]  C. Gogos,et al.  Dietary omega‐3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely ill patients with generalized malignancy , 1998, Cancer.

[3]  L. Moldawer,et al.  Proinflammatory cytokines, nutritional support, and the cachexia syndrome , 1997, Cancer.

[4]  L. Mosekilde,et al.  Components of variance when assessing the reproducibility of body composition measurements using bio-impedance and the Hologic QDR-2000 DXA scanner. , 1997, Clinical nutrition.

[5]  K. Fearon,et al.  Contribution of anorexia and hypermetabolism to weight loss in anicteric patients with pancreatic cancer , 1997, The British journal of surgery.

[6]  K. Fearon,et al.  Down-regulation of the acute-phase response in patients with pancreatic cancer cachexia receiving oral eicosapentaenoic acid is mediated via suppression of interleukin-6. , 1997, Clinical science.

[7]  K. Fearon,et al.  Changes in nutritional status associated with unresectable pancreatic cancer. , 1997, British Journal of Cancer.

[8]  C. McArdle,et al.  A pilot study of megestrol acetate and ibuprofen in the treatment of cachexia in gastrointestinal cancer patients. , 1997, British Journal of Cancer.

[9]  P. Lai,et al.  Cell cycle arrest and induction of apoptosis in pancreatic cancer cells exposed to eicosapentaenoic acid in vitro. , 1996, British Journal of Cancer.

[10]  Ahlgren Jd.  Epidemiology and risk factors in pancreatic cancer , 1996 .

[11]  N. Aaronson,et al.  Effects of medroxyprogesterone acetate on appetite, weight, and quality of life in advanced-stage non-hormone-sensitive cancer: a placebo-controlled multicenter study. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  K. Fearon,et al.  An open-label phase I/II dose escalation study of the treatment of pancreatic cancer using lithium gammalinolenate. , 1996, Anticancer research.

[13]  K. Fearon,et al.  Characterization of a cancer cachectic factor , 1996, Nature.

[14]  K. Fearon,et al.  The effect of polyunsaturated fatty acids on the progress of cachexia in patients with pancreatic cancer. , 1996, Nutrition.

[15]  M. Tisdale,et al.  Inhibition of lipolysis and muscle protein degradation by EPA in cancer cachexia. , 1996, Nutrition.

[16]  W. Hannan,et al.  Comparison of bio-impedance spectroscopy and multi-frequency bio-impedance analysis for the assessment of extracellular and total body water in surgical patients. , 1995, Clinical science.

[17]  E. Gold,et al.  Epidemiology of and risk factors for pancreatic cancer. , 1995, The Surgical clinics of North America.

[18]  J. Ross,et al.  Acute‐phase protein response and survival duration of patients with pancreatic cancer , 1995, Cancer.

[19]  K. Fearon,et al.  Effect of eicosapentaenoic acid and other fatty acids on the growth in vitro of human pancreatic cancer cell lines. , 1994, British Journal of Cancer.

[20]  J. Ross,et al.  Cytokines, the Acute‐Phase Response, and Resting Energy Expenditure in Cachectic Patients with Pancreatic Cancer , 1994, Annals of surgery.

[21]  E. L. Mortensen,et al.  Effect of dietary counseling on food intake, body weight, response rate, survival, and quality of life in cancer patients undergoing chemotherapy: a prospective, randomized study. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  H. Rasmussen,et al.  Immunologic effects of national cholesterol education panel step-2 diets with and without fish-derived N-3 fatty acid enrichment. , 1993, The Journal of clinical investigation.

[23]  E. L. Mortensen,et al.  The interrelationship of weight loss, dietary intake, and quality of life in ambulatory patients with cancer of the lung, breast, and ovary. , 1993, Nutrition and cancer.

[24]  D. Schaid,et al.  Body-composition changes in patients who gain weight while receiving megestrol acetate. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  J. Norton,et al.  Cytokines and their role in the pathophysiology of cancer cachexia. , 1992, JPEN. Journal of parenteral and enteral nutrition.

[26]  P. Weber,et al.  Cardiovascular effects of N-3 fatty acids. , 1988, Journal of nutritional science and vitaminology.

[27]  M. Tisdale,et al.  Anticachectic and antitumor effect of eicosapentaenoic acid and its effect on protein turnover. , 1991, Cancer research.

[28]  J V Castell,et al.  Interleukin-6 and the acute phase response. , 1990, The Biochemical journal.

[29]  H. Shizgal.  Validation of the measurement of body composition from whole body bioelectric impedance. , 1990, Infusionstherapie.

[30]  S. Ellenberg,et al.  A randomized study of oral nutritional support versus ad lib nutritional intake during chemotherapy for advanced colorectal and non-small-cell lung cancer. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  E. Dimagno,et al.  Assessment of weight loss, food intake, fat metabolism, malabsorption, and treatment of pancreatic insufficiency in pancreatic cancer , 1983, Cancer.

[32]  K. Rai,et al.  Changes in body composition of cancer patients following combined nutritional support. , 1982, Nutrition and cancer.

[33]  Joseph R. Bertino,et al.  Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. , 1980, The American journal of medicine.

[34]  M. Swaminathan.  Assessment of the nutritional status of the community. , 1969 .